Loading clinical trials...
Loading clinical trials...
A Single-Arm, Open Label, 16-week Extension Study to Evaluate the Efficacy and Safety of a Second Course of a Digital Therapeutic as an Adjunct to Standard of Care Antipsychotic Therapy in Adult and Late Adolescent Participants With Experiential Negative Symptoms of Schizophrenia
Conditions
Interventions
Study App
Locations
1
United States
Click Therapeutics
New York, New York, United States
Start Date
September 12, 2023
Primary Completion Date
June 13, 2025
Completion Date
August 22, 2025
Last Updated
October 16, 2025
NCT06894212
NCT04226898
NCT05240976
NCT07455929
NCT05304767
NCT06745479
Lead Sponsor
Click Therapeutics, Inc.
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions